insights_auto
Nega INO tushdi 2,05%?
Batafsil oʻrganishchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,43Â US$
arrow_downward
-2,05%(-0,030) 1K
13-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINO tikeri uchun statistika yaratilmoqda...
Ochish
1,44Â US$
Yuqori
1,48Â US$
Past
1,39Â US$
Bozor kapitali
267,85Â mln
Oʻrtacha hajm
19,26Â mln
Hajmi
5,22Â mln
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,57Â US$
Aksiya boʻyicha daromad
-0,80Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Ochish
1,44Â US$
Yuqori
1,48Â US$
Past
1,39Â US$
Bozor kapitali
267,85Â mln
Oʻrtacha hajm
19,26Â mln
Hajmi
5,22Â mln
52 haftalik eng yuqori
2,72Â US$
52 haftalik eng past
0,57Â US$
Aksiya boʻyicha daromad
-0,80Â US$
Beta
1,71
Muomaladagi aksiyalar
187,31Â mln
Xodimlar soni
112
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
News Corp
·
19 soat oldin
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals Inc haqida
CEOJacqueline Shea
Xodimlar soni112
Asos solingan1999
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytinovio.com